News

• Investor Relations

Notice of Resolutions Adopted at The 107th Ordinary General Meeting of Shareholders

• Investor Relations

Notice of resolutions adopted at the 107th ordinary general meeting of shareholders

• Investor Relations

Summary of Consolidated Financial Results For the Fiscal Year Ended March 31, 2019 [IFRS]

Nippon Shokubai Received the 12th Outstanding Achievement Award by the Japan OLED Forum:Development of OLED film light source thinner than paper　

<Press Conference Materials> Execution of a Basic Agreement Concerning the Consideration of Business Integration

Notice Regarding the Execution of a Basic Agreement Concerning the Consideration of Business Integration

• Investor Relations

Convocation Notice of The 107th Ordinary General Meeting of Shareholders

• Investor Relations

Convocation notice of the 107th ordinary general meeting of shareholders

• Investor Relations

Financial Results Briefing Material, Q4-FY2018

• Investor Relations

Consolidated Financial Results, Q4-FY2018 [JGAAP] 

• Investor Relations

Discontinuation of Countermeasures (Takeover Defense Measures) against Large-Scale Purchase of Nippon Shokubai Shares

• Investor Relations

Nippon Shokubai Announces Matters Regarding Dividends

• Investor Relations

Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2019

• Investor Relations

Views and Policy, etc. Regarding Investment Unit Reduction

Nippon Shokubai and Bizen Chemical Signed a Joint Development Agreement on Cosmetic Ingredients Utilized Chestnut Skin Extracts

Nippon Shokubai and Lilac Pharma Signed an Agreement on Business of Liposome Ingredients for Cosmetics

Notice Concerning Voluntary Adoption of International Financial Reporting Standards (IFRS)

• Investor Relations

Consolidated Financial Results, 3Q-FY 2018

• Investor Relations

Consolidated Financial Results, Q3-FY2018 

New Year’s Message to the Employees